Provided By PR Newswire
Last update: Sep 28, 2025
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:RCEL (9/29/2025, 12:50:24 PM)
5.52
+0.32 (+6.15%)
Find more stocks in the Stock Screener